APGE logo

Apogee Therapeutics (APGE) Shareholders equity

annual shareholders equity:

$716.79M+$336.88M(+88.67%)
December 31, 2024

Summary

  • As of today (June 18, 2025), APGE annual stockholders equity is $716.79 million, with the most recent change of +$336.88 million (+88.67%) on December 31, 2024.
  • During the last 3 years, APGE annual shareholders equity has risen by +$716.79 million (+100.00%).
  • APGE annual shareholders equity is now at all-time high.

Performance

APGE Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEbalance sheet metrics

quarterly shareholders equity:

$673.36M-$43.43M(-6.06%)
March 31, 2025

Summary

  • As of today (June 18, 2025), APGE quarterly stockholders equity is $673.36 million, with the most recent change of -$43.43 million (-6.06%) on March 31, 2025.
  • Over the past year, APGE quarterly shareholders equity has dropped by -$283.98 million (-29.66%).
  • APGE quarterly shareholders equity is now -29.66% below its all-time high of $957.34 million, reached on March 31, 2024.

Performance

APGE quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

APGE Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+88.7%-29.7%
3 y3 years+100.0%-
5 y5 years+100.0%-

APGE Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high>+9999.0%-29.7%>+9999.0%
5 y5-yearat high>+9999.0%-29.7%>+9999.0%
alltimeall timeat high>+9999.0%-29.7%>+9999.0%

APGE Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$673.36M(-6.1%)
Dec 2024
$716.79M(+88.7%)
$716.79M(-2.4%)
Sep 2024
-
$734.40M(-5.1%)
Jun 2024
-
$773.64M(-19.2%)
Mar 2024
-
$957.34M(+152.0%)
DateAnnualQuarterly
Dec 2023
$379.91M(>+9900.0%)
$379.91M(-24.2%)
Sep 2023
-
$501.28M(>+9900.0%)
Jun 2023
-
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
Dec 2022
$0.00
$0.00

FAQ

  • What is Apogee Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Apogee Therapeutics?
  • What is Apogee Therapeutics annual shareholders equity year-on-year change?
  • What is Apogee Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Apogee Therapeutics?
  • What is Apogee Therapeutics quarterly shareholders equity year-on-year change?

What is Apogee Therapeutics annual stockholders equity?

The current annual shareholders equity of APGE is $716.79M

What is the all time high annual shareholders equity for Apogee Therapeutics?

Apogee Therapeutics all-time high annual stockholders equity is $716.79M

What is Apogee Therapeutics annual shareholders equity year-on-year change?

Over the past year, APGE annual stockholders equity has changed by +$336.88M (+88.67%)

What is Apogee Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of APGE is $673.36M

What is the all time high quarterly shareholders equity for Apogee Therapeutics?

Apogee Therapeutics all-time high quarterly stockholders equity is $957.34M

What is Apogee Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, APGE quarterly stockholders equity has changed by -$283.98M (-29.66%)
On this page